Our Programs

Genespire’s lead program is an ex vivo cell therapy for X-linked Hyper IgM Syndrome. In addition, the company is working on further preclinical programs in other PIDs through correction in HSCs, and in inherited metabolic diseases though an in vivo liver-directed gene therapy approach.

 

Pipeline